ArticleCureus2022

Prospective Trial of Monocyte Count as a Biomarker of Hand-Foot Syndrome Among Patients With Soft Tissue Sarcomas Treated With Pegylated Liposomal Doxorubicin and Ifosfamide.

Keith M Skubitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.